A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data

<p dir="ltr">Sodium glucose cotransporter-2 (SGLT2) inhibitors and loop diuretics can cause volume depletion. However, the long-term safety of the concurrent use of both agents has not been widely evaluated. We conducted a retrospective observational cohort study to evaluate the safe...

Full description

Saved in:
Bibliographic Details
Main Author: Alaa Rahhal (14150403) (author)
Other Authors: Mostafa Najim (14150400) (author), Asad Abusweireh (17191855) (author), Masa Habra (17191858) (author), Lenah Elgassim (17191861) (author), Mohammed Omer Ali (17191864) (author), Mhd Baraa Habib (11721774) (author), Raad Tahtouh (14571110) (author), Mohammad Al-Awad (17191867) (author), Amer Hussien Aljundi (14150409) (author), Ahmed Mahfouz (737928) (author), Mohammed Thamer Ali (17191870) (author), Wafer Dabdoob (17191873) (author), Sumaya Alyafei (14147868) (author), Nidal Asaad (284935) (author)
Published: 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513549492027392
author Alaa Rahhal (14150403)
author2 Mostafa Najim (14150400)
Asad Abusweireh (17191855)
Masa Habra (17191858)
Lenah Elgassim (17191861)
Mohammed Omer Ali (17191864)
Mhd Baraa Habib (11721774)
Raad Tahtouh (14571110)
Mohammad Al-Awad (17191867)
Amer Hussien Aljundi (14150409)
Ahmed Mahfouz (737928)
Mohammed Thamer Ali (17191870)
Wafer Dabdoob (17191873)
Sumaya Alyafei (14147868)
Nidal Asaad (284935)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Alaa Rahhal (14150403)
Mostafa Najim (14150400)
Asad Abusweireh (17191855)
Masa Habra (17191858)
Lenah Elgassim (17191861)
Mohammed Omer Ali (17191864)
Mhd Baraa Habib (11721774)
Raad Tahtouh (14571110)
Mohammad Al-Awad (17191867)
Amer Hussien Aljundi (14150409)
Ahmed Mahfouz (737928)
Mohammed Thamer Ali (17191870)
Wafer Dabdoob (17191873)
Sumaya Alyafei (14147868)
Nidal Asaad (284935)
author_role author
dc.creator.none.fl_str_mv Alaa Rahhal (14150403)
Mostafa Najim (14150400)
Asad Abusweireh (17191855)
Masa Habra (17191858)
Lenah Elgassim (17191861)
Mohammed Omer Ali (17191864)
Mhd Baraa Habib (11721774)
Raad Tahtouh (14571110)
Mohammad Al-Awad (17191867)
Amer Hussien Aljundi (14150409)
Ahmed Mahfouz (737928)
Mohammed Thamer Ali (17191870)
Wafer Dabdoob (17191873)
Sumaya Alyafei (14147868)
Nidal Asaad (284935)
dc.date.none.fl_str_mv 2022-10-01T00:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.cpcardiol.2021.100995
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/A_Comparative_Study_of_Safety_Outcomes_of_Sodium_Glucose_Cotransporter-2_Inhibitors_and_Loop_Diuretics_Among_Diabetic_Patients_Using_Real-world_Data/24340066
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Comparative Study
sodium glucose cotransporter-2
Diabetic
world Data
dc.title.none.fl_str_mv A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Sodium glucose cotransporter-2 (SGLT2) inhibitors and loop diuretics can cause volume depletion. However, the long-term safety of the concurrent use of both agents has not been widely evaluated. We conducted a retrospective observational cohort study to evaluate the safety of SGLT2 inhibitors with loop diuretics vs SGLT2 inhibitors alone among diabetic patients. The primary endpoint was a composite of volume-depletion adverse events at 1 month and 12 months. Of the 400 patients included, 98 received SGLT2 inhibitors with a loop diuretic and 302 received SGLT2 inhibitors alone. The concurrent use of SGLT2 inhibitors and loop diuretics was tolerated at 1 month; however, it resulted in a significant increase in volume-depletion events at 12 months (10.2% vs 1.7%; aHR = 7.03, 95% CI (1.80-27.37), <i>P</i>-value = 0.005). In conclusion, the long-term concurrent use of SGLT2 inhibitors and loop diuretics increases the risk of volume depletion, warranting frequent monitoring.</p><h2>Other Information</h2><p dir="ltr">Published in: Current Problems in Cardiology<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.cpcardiol.2021.100995" target="_blank">https://dx.doi.org/10.1016/j.cpcardiol.2021.100995</a></p>
eu_rights_str_mv openAccess
id Manara2_6d43dc23c9b7175f009ef84743bf59ff
identifier_str_mv 10.1016/j.cpcardiol.2021.100995
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/24340066
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world DataAlaa Rahhal (14150403)Mostafa Najim (14150400)Asad Abusweireh (17191855)Masa Habra (17191858)Lenah Elgassim (17191861)Mohammed Omer Ali (17191864)Mhd Baraa Habib (11721774)Raad Tahtouh (14571110)Mohammad Al-Awad (17191867)Amer Hussien Aljundi (14150409)Ahmed Mahfouz (737928)Mohammed Thamer Ali (17191870)Wafer Dabdoob (17191873)Sumaya Alyafei (14147868)Nidal Asaad (284935)Biomedical and clinical sciencesCardiovascular medicine and haematologyClinical sciencesComparative Studysodium glucose cotransporter-2Diabeticworld Data<p dir="ltr">Sodium glucose cotransporter-2 (SGLT2) inhibitors and loop diuretics can cause volume depletion. However, the long-term safety of the concurrent use of both agents has not been widely evaluated. We conducted a retrospective observational cohort study to evaluate the safety of SGLT2 inhibitors with loop diuretics vs SGLT2 inhibitors alone among diabetic patients. The primary endpoint was a composite of volume-depletion adverse events at 1 month and 12 months. Of the 400 patients included, 98 received SGLT2 inhibitors with a loop diuretic and 302 received SGLT2 inhibitors alone. The concurrent use of SGLT2 inhibitors and loop diuretics was tolerated at 1 month; however, it resulted in a significant increase in volume-depletion events at 12 months (10.2% vs 1.7%; aHR = 7.03, 95% CI (1.80-27.37), <i>P</i>-value = 0.005). In conclusion, the long-term concurrent use of SGLT2 inhibitors and loop diuretics increases the risk of volume depletion, warranting frequent monitoring.</p><h2>Other Information</h2><p dir="ltr">Published in: Current Problems in Cardiology<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.cpcardiol.2021.100995" target="_blank">https://dx.doi.org/10.1016/j.cpcardiol.2021.100995</a></p>2022-10-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.cpcardiol.2021.100995https://figshare.com/articles/journal_contribution/A_Comparative_Study_of_Safety_Outcomes_of_Sodium_Glucose_Cotransporter-2_Inhibitors_and_Loop_Diuretics_Among_Diabetic_Patients_Using_Real-world_Data/24340066CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/243400662022-10-01T00:00:00Z
spellingShingle A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
Alaa Rahhal (14150403)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Comparative Study
sodium glucose cotransporter-2
Diabetic
world Data
status_str publishedVersion
title A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
title_full A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
title_fullStr A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
title_full_unstemmed A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
title_short A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
title_sort A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Comparative Study
sodium glucose cotransporter-2
Diabetic
world Data